These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 10370952

  • 21. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
    Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC.
    J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
    [Abstract] [Full Text] [Related]

  • 22. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
    Bastian PJ, Palapattu GS, Yegnasubramanian S, Lin X, Rogers CG, Mangold LA, Trock B, Eisenberger M, Partin AW, Nelson WG.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5361-7. PubMed ID: 17875764
    [Abstract] [Full Text] [Related]

  • 23. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
    Freedland SJ, Aronson WJ, Terris MK, Kane CJ, Amling CL, Dorey F, Presti JC, SEARCH Database Study Group.
    J Urol; 2003 Jun 15; 169(6):2136-41. PubMed ID: 12771735
    [Abstract] [Full Text] [Related]

  • 24. Volume-based evaluation of serum assays for new prostate-specific antigen isoforms in the detection of prostate cancer.
    Naya Y, Fritsche HA, Bhadkamkar VA, Mikolajczyk SD, Rittenhouse HG, Babaian RJ.
    Urology; 2004 Mar 15; 63(3):492-8. PubMed ID: 15028444
    [Abstract] [Full Text] [Related]

  • 25. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
    Akduman B, Alkibay T, Tuncel A, Bozkirli I.
    Can J Urol; 2000 Oct 15; 7(5):1104-9. PubMed ID: 11114873
    [Abstract] [Full Text] [Related]

  • 26. Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3).
    Aus G, Becker C, Lilja H, Khatami A, Pihl CG, Hugosson J.
    Scand J Urol Nephrol; 2003 Oct 15; 37(6):466-70. PubMed ID: 14675918
    [Abstract] [Full Text] [Related]

  • 27. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
    Shariat SF, Kattan MW, Song W, Bernard D, Gottenger E, Wheeler TM, Slawin KM.
    Cancer Res; 2003 Sep 15; 63(18):5874-8. PubMed ID: 14522912
    [Abstract] [Full Text] [Related]

  • 28. Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
    Graefen M, Karakiewicz PI, Cagiannos I, Hammerer PG, Haese A, Palisaar J, Huland E, Scardino PT, Kattan MW, Huland H.
    J Urol; 2002 Mar 15; 167(3):1306-9. PubMed ID: 11832719
    [Abstract] [Full Text] [Related]

  • 29. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ, Presti JC, Terris MK, Kane CJ, Aronson WJ, Dorey F, Amling CL, SEARCH Database Study Group.
    J Urol; 2003 Jun 15; 169(6):2129-35. PubMed ID: 12771734
    [Abstract] [Full Text] [Related]

  • 30. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy.
    Villamón-Fort R, Martínez-Jabaloyas JM, Soriano-Sarriá P, Ramos-Soler D, Pastor-Hernández F, Gil-Salom M.
    Urol Int; 2007 Jun 15; 78(4):328-33. PubMed ID: 17495491
    [Abstract] [Full Text] [Related]

  • 31. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM, Koch MO, Eble JN, Lin H, Cheng L.
    J Urol; 2006 May 15; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [Abstract] [Full Text] [Related]

  • 32. [Correlation between re-biopsy one year after endocrine therapy and long-term prognosis in localized prostate cancer].
    Kameoka H, Katayose K, Kumakawa K, Shiraiwa Y, Uchida H, Takahashi Y, Yazaki J, Yamaguchi O.
    Gan To Kagaku Ryoho; 2005 Jan 15; 32(1):57-63. PubMed ID: 15675583
    [Abstract] [Full Text] [Related]

  • 33. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA.
    BJU Int; 2006 Jan 15; 97(1):51-5. PubMed ID: 16336328
    [Abstract] [Full Text] [Related]

  • 34. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.
    Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L.
    Hum Pathol; 2007 Aug 15; 38(8):1207-11. PubMed ID: 17490720
    [Abstract] [Full Text] [Related]

  • 35. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
    Brausi M, Castagnetti G, Dotti A, De Luca G, Olmi R, Cesinaro AM.
    J Urol; 2004 Sep 15; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
    [Abstract] [Full Text] [Related]

  • 36. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?
    de la Taille A, Rubin MA, Bagiella E, Olsson CA, Buttyan R, Burchardt T, Knight C, O'Toole KM, Katz AE.
    J Urol; 1999 Jul 15; 162(1):103-6. PubMed ID: 10379750
    [Abstract] [Full Text] [Related]

  • 37. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.
    J Urol; 2005 Dec 15; 174(6):2181-5. PubMed ID: 16280760
    [Abstract] [Full Text] [Related]

  • 38. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
    Wetter A, Ajdukovic AN, Fliessbach K, Lehnert T, Engl T, Jacobi V, Vogl TJ.
    Rofo; 2006 Apr 15; 178(4):385-90. PubMed ID: 16607587
    [Abstract] [Full Text] [Related]

  • 39. [The assessment of pathological PSA values by the general practitioner--observation or intervention?].
    Braun KP, Brookman-Amissah S, May M, Grassmel Y, Hoschke B, Braun V.
    Aktuelle Urol; 2009 May 15; 40(3):171-4. PubMed ID: 19479670
    [Abstract] [Full Text] [Related]

  • 40. Side-specific factors associated with extracapsular extension and seminal vesicular invasion in men undergoing open radical retropubic prostatectomy.
    Sankin A, Tareen B, Lepor H.
    Prostate Cancer Prostatic Dis; 2009 May 15; 12(2):204-8. PubMed ID: 19238170
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.